Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
MicroRNA-133 controls cardiac hypertrophy
(This interplay reflects a broader tension: should critical drugs be controlled domestically or globally
Smaller Biotechs and Collaborators: Companies like Zealand Pharma, Glycadia, and others have GLP-1 analogs or co-agonists in early trials, often in partnership with larger pharma (e.g., Novo Nordisk collaboration with Zealand)
Personal model-assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD
US$ 28.41
US$ 29.83
US$ 27.71
US$ 29.54
US$ 28.16
US$ 26.62
US$ 22.17
US$ 21.96
US$ 23.18
US$ 21.75
